SARS-CoV-2 in Wildlife and Humans
Explore our science related to: SARS-CoV-2 in Wildlife and Humans
-
COVID-19 Pathways and Wildlife Dynamics
Below are the USGS 2020 Coronavirus Aid, Relief and Economic Security Act (CARES Act) research projects related to COVID-19 pathways and wildlife dynamics. Select tabs above for related items.Decision Science Support for SARS-CoV-2 Risk to North American Bats
The Eastern Ecological Science Center is working closely with federal, state, and tribal partners to help inform decisions that reduce the risk of SARS-CoV-2 transmission from humans to North American wildlife, including bats.
Related Content
Evaluating the risk of SARS-CoV-2 transmission to bats in the context of wildlife research, rehabilitation, and control
Collaborative hubs: Making the most of predictive epidemic modeling
Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing
Strategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making
Risks posed by SARS‐CoV‐2 to North American bats during winter fieldwork
The virus that causes COVID‐19 likely evolved in a mammalian host, possibly Old‐World bats, before adapting to humans, raising the question of whether reverse zoonotic transmission to bats is possible. Wildlife management agencies in North America are concerned that the activities they authorize could lead to transmission of SARS‐CoV‐2 to bats from humans. A rapid risk assessment conducted in Apri
Assessing the risks posed by SARS-CoV-2 in and via North American bats — Decision framing and rapid risk assessment
Decision-Support Tool to Estimate SARS-CoV-2 Human-to-bat Transmission Risk
Related Content
- Publications
Evaluating the risk of SARS-CoV-2 transmission to bats in the context of wildlife research, rehabilitation, and control
Preventing wildlife disease outbreaks is a priority for natural resource agencies, and management decisions can be urgent, especially in epidemic circumstances. With the emergence of SARS-CoV-2, wildlife agencies were concerned whether the activities they authorize might increase the risk of viral transmission from humans to North American bats, but had a limited amount of time in which to make deAuthorsJonathan D. Cook, Evan H. Campbell Grant, Jeremy T. H. Coleman, Jonathan M. Sleeman, Michael C. RungeCollaborative hubs: Making the most of predictive epidemic modeling
The COVID-19 pandemic has made it clear that epidemic models play an important role in how governments and the public understand and respond to infectious disease crises. In the early days of the COVID-19 pandemic, models were used first to estimate the true number of infections, then to provide estimates of key parameters, to generate short-term forecasts of outbreak trends, and to quantify the pAuthorsNicholas G. Reich, Justin Lessler, Sebastian Funk, Cecile Viboud, Alessandro Vespignani, Ryan J Tibshirani, Katriona Shea, Melanie Schienle, Michael C. Runge, Roni Rosenfeld, Evan L Ray, Rene Niehus, Helen C Johnson, Michael A Johansson, Harry Hochheiser, Lauren Gardner, Johannes Bracher, Rebecca K. Borchering, Matthew BiggerstaffSynergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing
Stay-at-home orders and shutdowns of non-essential businesses are powerful, but socially costly, tools to control the pandemic spread of SARS-CoV-2. Mass testing strategies, which rely on widely administered frequent and rapid diagnostics to identify and isolate infected individuals, could be a potentially less disruptive management strategy, particularly where vaccine access is limited. In this pAuthorsEmily Howerton, Matthew J. Ferrari, Ottar N Bjornstad, Tiffany L. Bogich, Rebecca K. Borchering, Chris P. Jewell, James D. Nichols, William J M Probert, Michael C. Runge, Michael J. Tildesley, Cecile Viboud, Katriona SheaStrategic testing approaches for targeted disease monitoring can be used to inform pandemic decision-making
More than 1.6 million Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) tests were administered daily in the United States at the peak of the epidemic, with a significant focus on individual treatment. Here, we show that objective-driven, strategic sampling designs and analyses can maximize information gain at the population level, which is necessary to increase situational awareness anAuthorsJames D. Nichols, Tiffany L. Bogich, Emily Howerton, Ottar N. Bjørnstad, Rebecca K. Borchering, Matthew J. Ferrari, Murali Haran, Christopher P. Jewell, Kim M. Pepin, William J. M. Probert, Juliet R. C. Pulliam, Michael C. Runge, Michael J. Tildesley, Cecile Viboud, Katriona SheaRisks posed by SARS‐CoV‐2 to North American bats during winter fieldwork
The virus that causes COVID‐19 likely evolved in a mammalian host, possibly Old‐World bats, before adapting to humans, raising the question of whether reverse zoonotic transmission to bats is possible. Wildlife management agencies in North America are concerned that the activities they authorize could lead to transmission of SARS‐CoV‐2 to bats from humans. A rapid risk assessment conducted in Apri
AuthorsJonathan D Cook, Evan H. Campbell Grant, Jeremy T. H. Coleman, Jonathan M. Sleeman, Michael C. RungeAssessing the risks posed by SARS-CoV-2 in and via North American bats — Decision framing and rapid risk assessment
The novel β-coronavirus, SARS-CoV-2, may pose a threat to North American bat populations if bats are exposed to the virus through interaction with humans, if the virus can subsequently infect bats and be transmitted among them, and if the virus causes morbidity or mortality in bats. Further, if SARS-CoV-2 became established in bat populations, it could possibly serve as a source for new infectionAuthorsMichael C. Runge, Evan H. Campbell Grant, Jeremy T. H. Coleman, Jonathan D. Reichard, Samantha E. J. Gibbs, Paul M. Cryan, Kevin J. Olival, Daniel P. Walsh, David S. Blehert, M. Camille Hopkins, Jonathan M. Sleeman - Web Tools
- Software
Decision-Support Tool to Estimate SARS-CoV-2 Human-to-bat Transmission Risk
Source code to run Shiny app of North American bat SARS2 risk model during winter fieldwork